- $1.46bn
- $1.38bn
- $534.53m
Brief: AtriCure Q1 Revenue USD 141.2 Million Vs. IBES Estimate USD 139.8 Million
AtriCure beats Q4 profit estimates
Brief: AtriCure Q4 Adjusted EPS USD 0.06 Vs. IBES Estimate USD -0.1
AtriCure's preliminary Q4 revenue rises 13%, slightly beats estimates
Brief: AtriCure Q4 Revenue USD 140.5 Million Vs. IBES Estimate USD 139.6 Million
Brief: Atricure Inc - Enters First Amendment To Credit Agreement - SEC Filing
U.S. RESEARCH ROUNDUP- Alphabet, Boeing, KLA
Medical device maker AtriCure beats Q3 revenue estimates
Brief: Atricure Reports Third Quarter 2025 Financial Results Raises Financial Outlook For 2025
Brief: AtriCure Q3 Adjusted EPS USD -0.01 Vs. IBES Estimate USD -0.12
Brief: AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
AtriCure Inc reports results for the quarter ended June 30 - Earnings Summary
AtriCure Q2 revenue beats estimates
AtriCure Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: AtriCure Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.23
U.S. RESEARCH ROUNDUP- Advanced Micro Devices, Carmax, Lockheed Martin
Brief: Atricure Files For Mixed Shelf; Size Not Disclosed - SEC Filing
U.S. RESEARCH ROUNDUP-Applovin, Equinix, Hubspot
Brief: Atricure Inc - Outlook FY Revenue Is Projected To Be Approximately $517 Million To $527 Million